Cutting edge iPSC and organoid technologies enabling advanced therapeutics
More than 97% iPSC reprogramming success rate – we can help
Our state-of-the-art stem cell technology is being used to enhance translational research and expand the number of human organoid models available to support research in Australia.
The Stem Cell and Organoid Facility operates on a fee-for-service basis to provide researchers with customised iPSC generation and differentiated cell types, including 3D organoids. Contact us for more information.
For purchase of existing, non-custom iPSC lines, visit CellBank.
Services
- Generation of iPS cells
- Maintenance of iPS cells
- Differentiation of iPS cells into tissues and organoids
- Functional analysis, including access to micro-electrode array technology
“Since 2019, we generated 56 iPSC lines with 97% reprogramming success.”
Dr Anai Gonzalez Cordero, Head of Stem Cell Medicine and SCOF
The Stem Cell & Organoid Facility is proudly supported by Luminesce Alliance and NSW Government, as well as Children’s Medical Research Institute.
Visit our main website for full details on our services.
Trusted Expertise
A/Prof Anai Gonzalez Cordero
Head of Stem Cell Medicine at CMRI and the STem Cell & Organoid Facility Lead
The Stem Cell & Organoid Facility is proudly supported by Luminesce Alliance and NSW Government, as well as Children’s Medical Research Institute.
